Riskpilot← Back to searchSign inGet full accessBYGG MED OSS AS
ASBankruptOrg 991477403Serviceveien 10, 1940 BjørkelangenDevelopment of building projects · NACE 6812Est. 20070 employees
Revenue 2022
NOK 233,7M
+70% vs 2021
EBITDA margin
-1.8%
-38% vs 2021
Equity ratio
-9.6%
Financial strength
Net profit 2022
NOK -4,5M
-36% vs 2021
| Revenue | NOK 233,7M | +70% |
| EBITDA | NOK -4,1M | -38% |
| Net profit | NOK -4,5M | -36% |
| Total assets | NOK 56,7M | +69% |
| Equity | NOK -5,5M | -472% |
| Employees | 0 | — |
Legal name
BYGG MED OSS AS
Org number
991477403
Legal form
Aksjeselskap
NACE code
6812 · Development of building projects
Founded
7. august 2007
Share capital
NOK 290 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Knut heggedal
Company purpose
Utvikling og regulering av områder, utvikle og selge disse sammen med andre aktører og bygge hus/hytter/forretningsbygg/driftsbygninger sammen med kunder, produsert av andre.
Address
Serviceveien 10, 1940 Bjørkelangen
Phone
+4790090046
Email
knut@byggmedoss.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 51 064 | 102 832 | 90 007 | 137 899 | 233 742 |
| Staff expenses | −6 336 | −13 112 | −12 256 | −13 853 | −15 340 |
| EBITDA | −3 581 | −92 | 2 763 | −3 012 | −4 149 |
| Depreciation & amort. | −66 | −107 | −103 | −110 | −147 |
| EBIT | −3 646 | −199 | 2 660 | −3 123 | −4 296 |
| Net financials | −161 | −677 | 358 | −187 | −206 |
| Profit before tax | −3 807 | −876 | 3 018 | −3 310 | −4 502 |
| Tax | −132 | −0 | −0 | −0 | −0 |
| Net profit | −3 675 | −876 | 3 018 | −3 310 | −4 502 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 12 707 | 28 082 | 25 268 | 33 629 | 56 739 |
| Equity | −1 285 | −2 161 | 2 357 | −953 | −5 455 |
| Long-term debt | 47 | 25 | 0 | 0 | 286 |
| Short-term debt | 13 945 | 30 218 | 22 911 | 34 582 | 61 909 |
| Total debt | 13 992 | 30 243 | 22 911 | 34 582 | 62 195 |
EBITDA margin
-1.8%
This company
15.8%
Market median
-111% vs market
20182022
Equity ratio
-9.6%
This company
38.2%
Market median
-125% vs market
20182022
Return on equity
-450216700.0%
This company
18.4%
Market median
-2446829991% vs market
20182022
Net profit margin
-1.9%
This company
8.1%
Market median
-123% vs market
20182022
Asset turnover
4.12×
This company
1.12×
Market median
+268% vs market
20182022
Debt / equity
11.40×
This company
0.62×
Market median
-1739% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 34.48% | 34.48% | 2022 | |
| Individual | 19.83% | 19.83% | 2022 | |
| Individual | 19.83% | 19.83% | 2022 | |
| Individual | 12.93% | 12.93% | 2022 | |
| Individual | 12.93% | 12.93% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BYGG MED OSS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ragnar Thor Grundtvig Søegaard | Chairman | 0 companies |
| Robert Hagen | Board of Directors | 0 companies |